Cetirizine dihydrochloride
important information for the patient.
This medicine should always be taken exactly as described in this patient leaflet or as directed by
your doctor or pharmacist.
The active substance of Zyrtec UCB is cetirizine dihydrochloride.
Zyrtec UCB is an antiallergic medicine.
Zyrtec UCB, 10 mg, film-coated tablets are indicated for adults and children aged 6 years and
older:
Before taking Zyrtec UCB, you should discuss it with your doctor or pharmacist.
If you have kidney problems, you should consult your doctor before taking the medicine; it may be
necessary to use a lower dose. The dose of the medicine will be determined by your doctor.
If you have problems with urination (e.g. spinal cord or prostate problems, or bladder problems), you
should consult your doctor.
If you have epilepsy or are at risk of seizures, you should consult your doctor.
No significant clinically relevant interactions have been observed between alcohol (at a concentration of
0.5 per mille (g/l) in the blood, corresponding to the concentration after drinking one glass of wine) and
cetirizine used at the recommended doses. However, there are no data on the safety of concomitant use
of higher doses of cetirizine and alcohol. Therefore, as with other antihistamine medicines, it is
recommended to avoid taking Zyrtec UCB with alcohol.
If you are scheduled to undergo allergy testing, you should ask your doctor whether you should stop taking
Zyrtec UCB a few days before the test. Zyrtec UCB may affect the results of allergy tests.
This medicine should not be given to children under 6 years of age, as the tablet formulation does not
allow for appropriate dose adjustment.
You should tell your doctor or pharmacist about all medicines you are taking or have recently taken, as
well as about medicines you plan to take.
Food does not affect the absorption of Zyrtec UCB.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, you
should consult your doctor before taking this medicine.
Zyrtec UCB should be avoided in pregnant women. Accidental intake of the medicine by a pregnant
woman should not have a harmful effect on the fetus. However, the medicine should only be used if
necessary and after consulting a doctor.
Cetirizine passes into breast milk. In breastfed infants, the risk of side effects cannot be excluded.
Therefore, Zyrtec UCB should not be taken during breastfeeding, unless your doctor recommends
otherwise.
Clinical studies have not shown any impairment of reaction time, attention, or ability to drive vehicles after
taking Zyrtec UCB at the recommended dose.
If you plan to drive vehicles, perform potentially hazardous activities, or operate machinery after taking
Zyrtec UCB, you should carefully observe your body's reaction to the medicine. You should not take a
higher dose than recommended.
Zyrtec UCB film-coated tablets contain lactose;if you have previously been diagnosed with an intolerance to
some sugars, you should contact your doctor before taking the medicine.
This medicine should always be taken exactly as described in this patient leaflet or as directed by your
doctor or pharmacist. If you are unsure, you should ask your doctor or pharmacist.
The tablets should be swallowed with a glass of liquid.
The tablet can be divided into 2 equal doses.
The recommended dose is 10 mg (1 tablet) once daily.
The recommended dose is 5 mg twice daily (half a tablet twice daily).
Other forms of this medicine may be more suitable for children. You should consult your doctor or
pharmacist.
In patients with moderate renal impairment, a dose of 5 mg once daily is recommended.
If you have severe kidney disease, you should consult your doctor, who will adjust the dose accordingly.
If your child has kidney disease, you should consult your doctor, who will adjust the dose according to your
child's needs.
If you feel that the effect of Zyrtec UCB is too strong or too weak, you should consult your doctor.
The duration of treatment depends on the type, duration, and course of symptoms. You should consult your
doctor or pharmacist.
Treatment with cetirizine without a doctor's recommendation should not last longer than 10 days.
If you have taken a higher dose of Zyrtec UCB than recommended, you should consult your doctor.
Your doctor will decide what measures should be taken.
After an overdose, the following side effects may occur with increased intensity: disorientation, diarrhea,
dizziness, fatigue, headache, malaise, dilated pupils, itching, restlessness, sedation, sleepiness, stupor,
increased heart rate, and urinary retention (difficulty emptying the bladder).
You should not take a double dose to make up for a missed dose.
In rare cases, itching (intense itching) and/or urticaria may recur after stopping treatment with Zyrtec UCB.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects(may affect up to 1 in 10 people)
Very rare side effects(may affect up to 1 in 10,000 people)
Side effects of unknown frequency(frequency cannot be estimated from the available data)
If you experience any side effects, including those not listed in the leaflet, you should tell your doctor or
pharmacist. Side effects can be reported directly to the Department for Monitoring of Adverse Reactions
to Medicinal Products, Medical Devices, and Biocides of the Office for Registration of Medicinal Products,
Medical Devices, and Biocides, Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22
49 21 309, website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister. The expiry date refers to the
last day of the month.
There are no special precautions for storage of the medicine.
White, elongated film-coated tablets with a dividing line and Y-Y logo.
The pack contains 7 or 10 film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorization holder:
VEDIM Sp. z o.o.
ul. Kruczkowskiego 8
00-380 Warsaw
Tel.: +48 22 696 99 20
Manufacturer:
Aesica Pharmaceuticals S.r.l.
Via Praglia 15
I-10044 Pianezza (TO), Italy
Importer:
PHOENIX Pharma Polska Sp z o.o.
ul. Rajdowa 9, Konotopa
05-850 Ożarów Mazowiecki
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.